Skip to content
DraconiticResearch
Search Sources API
181,713 studies31 sourcesUpdated 43 min ago
Peer-reviewedCC BY 4.0Antimicrobial Agents and Chemotherapy

Antifungal activity of the nucleoside mimetic 5-fluorouridine against Candidozyma auris and Candida species

  1. 1School of Chemical Engineering, Yeungnam University, Gyeongsan, Republic of Korea

Abstract

The emergence of multidrug-resistant Candidozyma auris has created an urgent need for antifungals with novel mechanisms of action. We screened 121 nucleoside and nucleobase derivatives against C. auris and other clinically relevant Candida species to identify effective antimetabolite scaffolds. Among all compounds tested, only the C-5-fluorinated nucleosides 5-fluorouridine (5-FU) and 5-fluorocytidine exhibited potent antifungal activity. 5-FU demonstrated consistently low minimum inhibitory concentrations (0.5–10 µg/mL) across multiple Candida species, including fluconazole-resistant strains, and displayed fungicidal activity against C. auris at concentrations lower than several frontline antifungals. Uridine rescue assays confirmed competitive interference with endogenous uridine metabolism. Checkerboard assays revealed synergistic or additive interactions between 5-FU and clinically used azoles and echinocandins. Toxicity evaluation using plant, nematode, and human cell models showed minimal cytotoxicity even at concentrations far exceeding antifungal minimum inhibitory concentrations. In silico docking analyses revealed dual inhibition of thymidylate synthase and RNA polymerase III, explaining the fungicidal phenotype and broad-spectrum efficacy. These findings identify 5-fluorouridine as a promising antifungal candidate and establish C-5-halogenated nucleosides as a privileged scaffold for antifungal drug development.

Related

  1. Antimicrobial Peptoids Show Potent Antifungal Activity against Candidozyma (Candida) auris In Vivo and Broad-Spectrum Activity In Vitro against Other Candida Species.
    Lisa K Ryan, Isabella M Griffiths, Uyen Emily Do +8
    ACS infectious diseasesPeer-reviewedCC BYFull textInfectious diseaseEurope PMC
  2. A C‐Nucleoside Analogue of Cordycepin With High Metabolic Stability and Potent Anti‐Psoriatic Activity via Microneedle Delivery
    Wenfang Pan, Xinyue Shao, Yuanchen Zhong +5
    Advanced SciencePeer-reviewedCC BY 4.0Full textPharmacology & toxicologyPMC
  3. Nanoformulated silymarin enhances antifungal activity against resistant Candida albicans by reducing ergosterol and binding to cell envelope targets
    Melika Ghodrati, Aghil Sharifzadeh, Bahar Nayeri Fasaei +3
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textInfectious diseaseCrossref
  4. The antibacterial and antifungal activity of honey and propolis from the Australian stingless bee Tetragonula carbonaria
    Jasmin Li, Rosalyn Gloag, Dee A Carter +1
    PLOS OnePeer-reviewedCC BYFull textMicrobiologyZoology & animal behaviourPLOSEurope PMC
  5. Sodium Butyrate Alleviates Fungal Keratitis by Exerting Antifungal Activity and Dampening Inflammation Through the Nrf2/HO-1 Axis
    Zhaoyang Zhang, Ziyue Zhang, Huijin Duan +6
    Investigative Ophthalmology & Visual SciencePeer-reviewedCC BY-NC-ND 4.0Full textGeneral medicinePMC
BibTeX
@article{boya2026antifungal,
  title = {{Antifungal activity of the nucleoside mimetic 5-fluorouridine against Candidozyma auris and Candida species}},
  author = {Bharath Reddy Boya and Ezhaveni Sathiyamoorthi and Jin-Hyung Lee and Jintae Lee},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2026},
  month = aug,
  doi = {10.1128/aac.00027-26},
  url = {https://doi.org/10.1128/aac.00027-26},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Antifungal activity of the nucleoside mimetic 5-fluorouridine against Candidozyma auris and Candida species
AU  - Bharath Reddy Boya
AU  - Ezhaveni Sathiyamoorthi
AU  - Jin-Hyung Lee
AU  - Jintae Lee
PY  - 2026
DA  - 2026/08/14
JO  - Antimicrobial Agents and Chemotherapy
DO  - 10.1128/aac.00027-26
UR  - https://doi.org/10.1128/aac.00027-26
AB  - The emergence of multidrug-resistant Candidozyma auris has created an urgent need for antifungals with novel mechanisms of action. We screened 121 nucleoside and nucleobase derivatives against C. auris and other clinically relevant Candida species to identify effective antimetabolite scaffolds. Among all compounds tested, only the C-5-fluorinated nucleosides 5-fluorouridine (5-FU) and 5-fluorocytidine exhibited potent antifungal activity. 5-FU demonstrated consistently low minimum inhibitory concentrations (0.5–10 µg/mL) across multiple Candida species, including fluconazole-resistant strains, and displayed fungicidal activity against C. auris at concentrations lower than several frontline antifungals. Uridine rescue assays confirmed competitive interference with endogenous uridine metabolism. Checkerboard assays revealed synergistic or additive interactions between 5-FU and clinically used azoles and echinocandins. Toxicity evaluation using plant, nematode, and human cell models showed minimal cytotoxicity even at concentrations far exceeding antifungal minimum inhibitory concentrations. In silico docking analyses revealed dual inhibition of thymidylate synthase and RNA polymerase III, explaining the fungicidal phenotype and broad-spectrum efficacy. These findings identify 5-fluorouridine as a promising antifungal candidate and establish C-5-halogenated nucleosides as a privileged scaffold for antifungal drug development.
SN  - 0066-4804
SN  - 1098-6596
ER  -